UK-based molecular diagnostics developer Lumora has partnered with the Foundation for Innovative New Diagnostics to develop a rapid, high-throughput malaria diagnostic assay to screen patients in the developing world.
Germany Funds $3.7M for Aging Immunity
The Helmholtz Centre-led systems biology project will include public and private partners and will seek to study how the human immune system ages.
IZI Scientists Building Point-of-Care Device to Measure Lung Cancer Biomarkers in Patient Breath
The device, which the scientists are developing under a two-year, €1.3 million grant from Germany's Federal Ministry of Education and Research, uses cytometric bead arrays to quantitate protein biomarkers in patients' exhaled breath condensate.
Magna is spearheading a public-private consortium to develop a point-of-care molecular testing platform based on magnetic nanoparticles and PCR amplification. Other partners in the consortium include the Fraunhofer Institute and Siemens.
MorphoSys to Use BMBF Grant to Look at Protein Biomarkers for Multiple Myeloma Drug Efficacy
The company will use part of the €1 million award to investigate biomarkers that will aid in determining which patients are the best candidates for treatment with its MOR202 antibody program, a company official said.
Jul 21, 2009
Feb 17, 2009
Feb 17, 2009